Reason for request
Inscription
Clinical Benefit
Substantial |
le service médical rendu par DROPERIDOL PANPHARMA 5 mg/ 2 ml est important dans l’indication de l’AMM.
|
Clinical Added Value
no clinical added value |
Absence d’amélioration du service médical rendu (ASMR V, inexistante) par rapport aux autres spécialités à base de dropéridol déjà inscrites.
|
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
7hHk4rcJUa50q2QP